The risks and benefits of hormone replacement therapy before and after a breast cancer diagnosis
Author:
Affiliation:
1. Medical Advisory Council, The British Menopause Society, UK
2. Statistical Modelling, University of Bristol, UK
Publisher
SAGE Publications
Subject
Obstetrics and Gynecology
Link
http://journals.sagepub.com/doi/pdf/10.1177/2053369120956636
Reference34 articles.
1. Informed choice: is it achievable?
2. An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint ® )
3. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials
4. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
5. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Authors reply: ‘Response to the British Menopause society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology position statement – Best practice recommendations for the care of women experiencing the menopause’;Post Reproductive Health;2022-11-14
2. Looking at HRT in perspective;BMJ;2022-06-15
3. Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development;The Cancer Journal;2022-05
4. Developing the Women’s health strategy: The British Menopause Society’s recommendations to the department of health and social care’s call for evidence;Post Reproductive Health;2022-01-05
5. A case vignette describing management of menopausal symptoms and migraine in the perimenopause;BMJ Sexual & Reproductive Health;2021-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3